FrederickBStehmanMD
Obstetrics & Gynecology • Indianapolis, INGynecologic Oncology
Professor Emeritus of Obstetrics & Gynecology, Indiana University
Are you Dr. Stehman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 57 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
550 University Blvd
UH 2440
Indianapolis, IN 46202Phone+1 317-274-1661Fax+1 317-278-9918
Summary
- Dr. Frederick Stehman, MD is an obstetrician/gynecologist in Indianapolis, Indiana. He is currently licensed to practice medicine in Indiana. He is affiliated with Indiana University Health University Hospital and Eskenazi Health.
Education & Training
University of Kansas School of MedicineResidency, Surgery, 1975 - 1977- University of Kansas School of MedicineResidency, Obstetrics and Gynecology, 1972 - 1975
University of Michigan Medical SchoolClass of 1972
Certifications & Licensure
IN State Medical License 1979 - 2019- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Indianapolis Monthly Castle Connolly, 2007, 2009-2011, 2013
- Join now to see all
Publications & Presentations
PubMed
- 56 citationsAn evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum ther...Kate E. Oliver, William E. Brady, Michael J. Birrer, David M. Gershenson, Gini F. Fleming
Gynecologic Oncology. 2017-11-01 - 378 citationsBevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncolog...Krishnansu S. Tewari, Michael W. Sill, Richard T. Penson, Helen Huang, Lois M. Ramondetta
Lancet. 2017-10-07 - 6 citationsDisease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic ...Peter G. Rose, James J. Java, Mark A. Morgan, A. Alvarez-Secord, Joshua Kesterson
Gynecologic Oncology. 2016-12-01
Grant Support
- Gynecologic Oncology Group-Indiana UniversityNational Cancer Institute1986–1989
Professional Memberships
- Member
- Fellow
